scispace - formally typeset
Open AccessJournal Article

Clinical and biomarker changes in dominantly inherited alzheimer's disease

TLDR
It is found that autosomal dominant Alzheimer's disease was associated with a series of pathophysiological changes over decades in CSF biochemical markers of Alzheimer’s disease, brain amyloid deposition, and brain metabolism as well as progressive cognitive impairment.
About
This article is published in Clinical and Experimental Pharmacology and Physiology.The article was published on 2013-10-01 and is currently open access. It has received 642 citations till now. The article focuses on the topics: Biomarker (medicine).

read more

Citations
More filters
Journal ArticleDOI

The amyloid hypothesis of Alzheimer's disease at 25 years

TL;DR: In a recent study, this article showed that low cerebrospinal fluid (CSF) Aβ42 and amyloid-PET positivity precede other AD manifestations by many years.
Journal ArticleDOI

Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria

TL;DR: It is proposed that downstream topographical biomarkers of the disease, such as volumetric MRI and fluorodeoxyglucose PET, might better serve in the measurement and monitoring of the course of disease.
Journal ArticleDOI

CSF and blood biomarkers for the diagnosis of Alzheimer's disease: a systematic review and meta-analysis

TL;DR: The core CSF biomarkers of neurodegeneration (T-tau, P-tAU, and Aβ42), CSF NFL, and plasma T-t Tau were strongly associated with Alzheimer's disease and the core biomarkers were strong associated with mild cognitive impairment due to Alzheimer's Disease.
Journal ArticleDOI

Preclinical Alzheimer's disease: Definition, natural history, and diagnostic criteria.

TL;DR: An updated review of the literature and evidence on the definitions and lexicon, the limits, the natural history, the markers of progression, and the ethical consequence of detecting the disease at this asymptomatic stage of Alzheimer's disease are provided.
Related Papers (5)